222 related articles for article (PubMed ID: 28623614)
1. AbobotulinumtoxinA: A Review in Pediatric Lower Limb Spasticity.
Syed YY
Paediatr Drugs; 2017 Aug; 19(4):367-373. PubMed ID: 28623614
[TBL] [Abstract][Full Text] [Related]
2. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
Delgado MR; Tilton A; Carranza-Del Río J; Dursun N; Bonikowski M; Aydin R; Maciag-Tymecka I; Oleszek J; Dabrowski E; Grandoulier AS; Picaut P;
Dev Med Child Neurol; 2021 May; 63(5):592-600. PubMed ID: 33206382
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy.
Delgado MR; Bonikowski M; Carranza J; Dabrowski E; Matthews D; Russman B; Tilton A; Velez JC; Grandoulier AS; Picaut P
J Child Neurol; 2017 Nov; 32(13):1058-1064. PubMed ID: 28914131
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
Gracies JM; Esquenazi A; Brashear A; Banach M; Kocer S; Jech R; Khatkova S; Benetin J; Vecchio M; McAllister P; Ilkowski J; Ochudlo S; Catus F; Grandoulier AS; Vilain C; Picaut P;
Neurology; 2017 Nov; 89(22):2245-2253. PubMed ID: 29093068
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
Guyot P; Kalyvas C; Mamane C; Danchenko N
J Child Neurol; 2019 Jun; 34(7):371-381. PubMed ID: 30803305
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
Johnston K; Danchenko N; Hansen R; Dinet J; Liovas A; Armstrong A; Bains S; Sullivan SD
J Med Econ; 2020 Jun; 23(6):631-640. PubMed ID: 31985313
[No Abstract] [Full Text] [Related]
9. Switching from onabotulinumtoxin-A to abobotulinumtoxin-A in children with cerebral palsy treated for spasticity: A retrospective safety and efficacy evaluation.
Dursun N; Akarsu M; Gokbel T; Akyuz M; Karacan C; Dursun E
J Rehabil Med; 2019 May; 51(5):390-394. PubMed ID: 30931483
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
Esquenazi A; Stoquart G; Hedera P; Jacinto LJ; Dimanico U; Constant-Boyer F; Brashear A; Grandoulier AS; Vilain C; Picaut P; Gracies JM
PM R; 2020 Sep; 12(9):853-860. PubMed ID: 32108436
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
[TBL] [Abstract][Full Text] [Related]
13. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
O'Dell MW; Brashear A; Jech R; Lejeune T; Marque P; Bensmail D; Ayyoub Z; Simpson DM; Volteau M; Vilain C; Picaut P; Gracies JM
PM R; 2018 Jan; 10(1):1-10. PubMed ID: 28634000
[TBL] [Abstract][Full Text] [Related]
14. AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.
Delgado MR; Tilton A; Russman B; Benavides O; Bonikowski M; Carranza J; Dabrowski E; Dursun N; Gormley M; Jozwiak M; Matthews D; Maciag-Tymecka I; Unlu E; Pham E; Tse A; Picaut P
Pediatrics; 2016 Feb; 137(2):e20152830. PubMed ID: 26812925
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
[TBL] [Abstract][Full Text] [Related]
16. IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
Dabrowski E; Chambers HG; Gaebler-Spira D; Banach M; Kaňovský P; Dersch H; Althaus M; Geister TL; Heinen F
Pediatr Neurol; 2021 Oct; 123():10-20. PubMed ID: 34339951
[TBL] [Abstract][Full Text] [Related]
17. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
Hubble J; Schwab J; Hubert C; Abbott CC
Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A treatment of adult upper and lower limb spasticity.
Hesse S; Brandi-Hesse B; Bardeleben A; Werner C; Funk M
Drugs Aging; 2001; 18(4):255-62. PubMed ID: 11341473
[TBL] [Abstract][Full Text] [Related]
20. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
